SAVIMS

SAVIMS logo white
Menu

Resource Type

COVID-19, Ethics, Other scientific evidence, Reference Library, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Rising Hospitalisations Among Vaccinated Individuals in Israel

| | COVID-19, Ethics, Other scientific evidence, Reference Library, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Johnson, L. D. (2021, August 11). 95% of severe patients in Israeli hospitals are vaccinated, warns doctor. Natural News. https://www.naturalnews.com/2021-08-11-95-severe-patients-israeli-hospitals-are-vaccinated.html Summary: Dr. Kobi Haviv reports a troubling trend in Israel, where 95% of severe COVID-19 patients in hospitals are vaccinated. Despite over 78% vaccination coverage, Israel has experienced a rise in serious cases. The […]

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Shedding of Infectious SARS-CoV-2 Despite Vaccination

| | COVID-19, Covid-19 vaccines, Epidemiological surveillance, Other scientific evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Riemersma, K. K., Haddock, L. A. III, Wilson, N. A., Minor, N., Eickhoff, J., Grogan, B. E., Kita-Yarbro, A., Halfmann, P. J., Segaloff, H. E., Kocharian, A., Florek, K. R., Westergaard, R., Bateman, A., Jeppson, G. E., Kawaoka, Y., O’Connor, D. H., Friedrich, T. C., & Grande, K. M. (2022). Shedding of infectious SARS-CoV-2

COVID-19, Ivermectin, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Ivermectin for COVID-19: Evidence Review

| | COVID-19, Ivermectin, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: South African National Department of Health. (2021). Rapid review of Ivermectin for COVID-19: Evidence review of clinical benefits and harms (Update: 30 July 2021). Summary: The South African National Department of Health conducted a rapid review to assess the efficacy of ivermectin in treating COVID-19. The review, which synthesised findings from multiple randomised controlled

COVID-19, Covid-19 vaccines, Epidemiological surveillance, Peer-reviewed evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Impact of the SARS-CoV-2 Delta Variant and Vaccine Efficacy

| | COVID-19, Covid-19 vaccines, Epidemiological surveillance, Peer-reviewed evidence, Resource Type, Statistical evidence, Vaccine effectiveness, Vaccines, Viral illnesses

Reference: Tareq, A. M., Bin Emran, T., Dhama, K., Dhawan, M., & Tallei, T. E. (2021). Impact of SARS-CoV-2 delta variant (B.1.617.2) in surging second wave of COVID-19 and efficacy of vaccines in tackling the ongoing pandemic. Human Vaccines & Immunotherapeutics, 17(11), 4126–4127. https://doi.org/10.1080/21645515.2021.1963601 Summary: The article examines the impact of the SARS-CoV-2 delta variant

COVID-19, Ivermectin, Other scientific evidence, Resource Type, Treatment, Viral illnesses

A database of all Ivermectin studies for treatment of COVID-19

| | COVID-19, Ivermectin, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: Search results obtained to compile a database of all the studies done on Ivermecting as therapeutic drug for COVID-19. 2021-07-18. Summary: Database of all Ivermectin COVID-19 studies. 101 studies, 66 peer reviewed, 60 with results comparing treatment and control groups. DOWNLOAD

COVID-19, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Breakthrough Infections Post-Pfizer Vaccination: Insights from an Israeli Study

| | COVID-19, Other scientific evidence, Resource Type, Vaccine effectiveness, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Brosh-Nissimov, T. et al. (2021). BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully-vaccinated hospitalized COVID-19 patients in Israel. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2021.06.036 Summary: A study conducted in Israel examined breakthrough infections in fully-vaccinated patients who were hospitalised with COVID-19. Out of 152 patients, 40% were immunocompromised, and the study revealed that despite the

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Community Health Initiative Against Covid-19

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: Okahandja Community Forum. (2021, July 9). An Okahandja community project: What you can do at home. Summary: The Okahandja community project, initiated on 9 July 2021, provides guidance for individuals on how to manage health concerns related to Covid-19. Emphasising the importance of prevention and patient support, the document outlines necessary hygiene measures, such

COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccine safety & adverse events, Vaccines, Viral illnesses

Should COVID-19 Vaccination in Children be Mandatory?

| | COVID-19, Covid-19 vaccines, Peer-reviewed evidence, Resource Type, Vaccine effectiveness, Vaccine risk benefit analysis, Vaccine safety & adverse events, Vaccines, Viral illnesses

Reference: Benn, C. S., & Aaby, P. (2021). Should COVID-19 be a vaccine disease or a childhood disease? The BMJ, 374, n1687. https://doi.org/10.1136/bmj.n1687 Summary: The article discusses the implications of COVID-19 vaccination for children, highlighting concerns over the safety and necessity of such measures. It critiques the small sample size of the Pfizer phase 3

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Insights into COVID-19 Management

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: Wucher, M. (2021). COVID-19 – Ask your doctor: What you should know today. Retrieved from [source link] Summary: Dr Martin Wucher’s guide offers critical insights into managing COVID-19, emphasising the importance of immune system readiness before, during, and after infection. He advises against self-medication and promotes seeking professional medical advice. The guide underscores the

COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

The Good News About COVID-19

| | COVID-19, Ivermectin, Nutritional supplements, Other repurposed substances, Other scientific evidence, Resource Type, Treatment, Viral illnesses

Reference: Edeling, H. J. (2021). The good news about COVID-19. Retrieved from https://emlct.com/wp-content/uploads/2021/08/COVID-19-BlindFaithOrOpenMinds-LH.pdf Summary: In “The Good News About COVID-19,” Dr. Herman J. Edeling presents an overview of the scientific advancements regarding the prevention and treatment of COVID-19. He emphasises the rigorous studies that have identified safe, effective, and inexpensive methods to both prevent and

Scroll to Top